INDmoney
Alkem Labs Share Price
₹5684.00
+21.50
(+0.38%)
as on
🔔 Merger Alert
Alkem Laboratories board supports merger of Alkem Medtech Ortho Pvt Ltd with Alkem Medtech Pvt Ltd, pending NCLT approval and shareholder consent.
Alkem Labs Stock Performance
as on February 6, 2026 at 9:31 pm IST
Day's Low
Day's High
₹5,569.00₹5,706.00
2.02%
Downside
0.39%
Upside
52 Week's Low
52 Week's High
₹4,491.65₹5,933.5020.98%
Downside
4.39%
Upside
Alkem Labs share price movements today
- Previous Close
- ₹5,662.50
- Open
- ₹5,683.00
- Volume
- 52.72K
- Upper Circuit
- ₹6,228.50
- Lower Circuit
- ₹5,096.50
- Day's Low - High
- ₹5,569.00 - ₹5,706.00
- 52 Week Low - High
- ₹4,491.65 - ₹5,933.50
Alkem Labs Historical Returns
- 1 Month Return
- + 0.12 %
- 3 Month Return
- + 0.34 %
- 1 Year Return
- + 7.74 %
- 3 Year Return
- + 84.55 %
- 5 Year Return
- + 95.13 %
Alkem Labs Fundamentals
as on February 6, 2026 at 4:01 pm IST
Market Cap
₹67,703.68 Cr
Return on Equity (ROE)
19.94
PE Ratio (TTM)
28.68
Return on capital employed (ROCE)
20.29
Industry PE ratio
40.92
Beta (LTM)
0.7
P/B Ratio
4.73
Dividend Yield
0.92
PEG Ratio
1.44
Quarterly Earnings Growth YOY
11.06
EPS (TTM)
185.36
Sector
Pharmaceuticals
Book Value
1002.5
Technical Analysis
Bullish
View Technical Analysis
Alkem Labs Stock Valuation
as on February 6, 2026 at 4:01 pm IST
Alkem Labs in the last 5 years
Lowest (20.07x)
March 24, 2021
Today (28.68x)
February 5, 2026
Industry (40.92x)
February 5, 2026
Highest (44.21x)
August 9, 2023
Today’s Price to Earnings Ratio: 28.68x
Alkem Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Alkem Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 67,703.68 | 19.03% | 0.59 | 2,216 | 12,964 | |
| BUY | 23,642.01 | 3.42% | 0.54 | 492 | 2,461 | |
| HOLD | 52,039.48 | 33.97% | 0.71 | 354 | 5,553 | |
| BUY | 9,995.90 | 11.33% | 0.65 | 143 | 704 | |
| BUY | 6,369.65 | 5.55% | 0.53 | 90 | 687 |
Analyst Recommendation on Alkem Labs Stock
Based on 21 analysts
47.62%
Buy
28.57%
Hold
23.81%
Sell
Based on 21 analysts, 47.62% of analysts recommend a 'HOLD' rating for Alkem Labs. Average target price of ₹5974.76
Source: S&P Global Market Intelligence
Alkem Labs Share Price Target
Get share price movements and forecasts by analysts on Alkem Labs.
What analysts predicted
5.51%UPSIDE
Target Price
₹5974.76
Current Price
₹5684
Analyzed by
21 Analysts
High
₹7056
Target
₹5974.76
Low
₹4280
Alkem Labs target price ₹5974.76, a slight upside of 5.51% compared to current price of ₹5684. According to 21 analysts rating.
Source: S&P Global Market Intelligence
Alkem Labs Stock’s Investor Sentiment and Interest
Search interest for Alkem Laboratories Ltd Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:66% versus previous 30 day period
Alkem Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Alkem Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Alkem Laboratories Ltd Cash Flow
Figures in Rupees Crores
Alkem Labs Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Alkem Labs Stock
Check out the Mutual Funds with significant holdings in Alkem Labs.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Mid Cap Fund -Direct Plan - Growth Option | 1.07% | 1802978 | |
 SBI Large & Midcap Fund Direct Growth | 2.17% | 1476712 | Here |
 ICICI Prudential Multi-Asset Fund Direct Plan Growth | 1.02% | 1450072 | Here |
 Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap | 1.52% | 1163397 | Here |
ICICI Prudential Large & Mid Cap Fund Direct Plan Growth | 2.23% | 1121797 | Here |
Alkem Labs Corporate Actions
View detailed summary of the earnings and dividend history of Alkem Labs.
Alkem Laboratories Ltd Earnings Results
Alkem Laboratories Ltd’s net profit jumped 11.1% since last year same period to ₹765.06Cr in the Q2 2025-2026. On a quarterly growth basis, Alkem Laboratories Ltd has generated 15.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsAlkem Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Alkem Laboratories Ltd has declared dividend of ₹8.00 per share on 29 May 2025 - translating a dividend yield of 0.88%.
Read More about Dividends
Indices Featuring Alkem Labs Stock
Check stock indices that include Alkem Labs.
Insights on Alkem Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 305.86 Cr → 765.06 Cr (in ₹), with an average increase of 33.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, ALKEM stock has moved up by 16.3%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 3.28K Cr → 4.10K Cr (in ₹), with an average increase of 10.4% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 9.48% to 9.97% in Dec 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 51.20% of holdings in Dec 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.6% return, outperforming this stock by 73.1%
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 25.8% return, outperforming this stock by 18.0%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 16.94% to 16.06% in Dec 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 17.40% to 17.30% in Dec 2025 quarter
Alkem Labs Stock Futures & Options Contracts
View the latest movement in Alkem Labs Futures & Options, including strike prices, expiry dates, and percentage changes.
Alkem Labs Options
Alkem Labs Futures
About Alkem Laboratories Ltd
With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.
Revenue: ₹4,000.99Cr as on September 2025 (Q2 FY26)
Net Profit: ₹779.60Cr as on September 2025 (Q2 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
| Organisation | Alkem Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Basudeo N Singh |
| E-voting on shares | Click here to vote |
FAQs
What is Alkem Labs share price today?
Alkem Labs share price today stands at ₹5684 as on at the close of the market. Alkem Labs share today touched a day high of ₹5706 and a low of ₹5569.
What is the 52 week high and 52 week low range for Alkem Labs share?
Alkem Labs touched a 52 week high of ₹5933.5 and a 52 week low of ₹4491.65. Alkem Labs share price today i.e. is closed at ₹5684, which is -4.20% down from its 52 week high and 26.55% up from its 52 week low.
What is Alkem Labs's market capitalisation today?
Alkem Labs market capitalisation is ₹67,703.68 Cr as on .
How to buy Alkem Labs shares?
To buy Alkem Labs shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ALKEM or Alkem Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Alkem Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Alkem Labs trading volume today?
Alkem Labs trading volume is 52.72K as on . This means that 52.72K shares of Alkem Labs were bought and sold on the stock market during today's trading session.